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Effect of Celastrol on Notch Signaling Pathway in IgA Nephropathy Rats
Liu Dan, Wang CL
The First Affiliated Hospital Of Baotou Medical College, Baotou, Inner
Mongolia, China
Objective: To investigate the effect of celastrol on expression of Notch
signaling pathway in renal tissues of IgA nephropathic rats.
Methods: Rat model of IgA nephropathy was established to observe the hema-
turia andproteinuria statuses in rats after celastrol treatment. Expression levels
of Notch1, Jagged1 and downstream target genes Hes1, Hey1 were detected by
immunohistochemistry and real-time fluorescence quantitative PCR.
Results: Celastrol can alleviate hematuria and proteinuria in IgA nephro-
pathic rats (P < 0.05), and decrease expression levels of Notch1, Jagged1
and downstream target genes Hes1, Hey1 in renal tissues of IgA nephropathic
rats (P < 0.05 or P < 0.01). Besides, 10 mg/kg/d celastrol was more effective
than 1 mg/kg/d celastrol (P < 0.05).
Conclusion: Celastrol can reduce the production of hematuria and protein-
uria by inhibiting the expression of Notch signaling pathway in renal tissues
of IgA nephropathic rats, and thereby exerts a therapeutic effect in rat IgA
nephropathy.Figure 1 24h urinary protein levels of each group after treatment.http://dx.doi.org/10.1016/j.hkjn.2015.08.109
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Leflunomide Combined Hormone Therapy Curative Effect Observation
of IgA Nephropathy
Wenhua Liu, Wenbo Hu
Department of Urology, Qinghai Province People’s Hospital, Xining, Qinghai,
China
Objective: To observe the curative effect of leflunomide combined gluco-
corticoid therapy of IgA nephropathy, evaluating its effect.
Methods: (1) The 30 patients who were diagnosed IgA nephropathy by renal
biopsy between December 2013 and March in Qinghai Province People’s Hos-
pital, urine protein quantity of 24 hours > 3.5 g/d, serum creatinine < 265
umol/L. (2) Experimental group given hormone joint induced by fluorine.
The induction dose of 30 mg/d, after three days 20 mg/d, changed to
10mg/d after 7 days, administered at draught daily morning, at least tomain-
tain 24 weeks. Hormone therapy initial dose of 1 mg/kg/d, slow reduction on
the basis of curative effect, from 8 to 12 weeks, reducing 5 mg every 2 weeks,
to 10 mg/d lasts 3 months gradually stopped, the control group only give
glucocorticoid. (3) Monitoring patients’ indicators such as urine protein quan-
tity of 24 hours, serum albumin level, serum creatinine. Disease recurrence
before and 4 weeks treatment, 8 weeks, 12 weeks and 24 weeks, 36 weeks.
Results: After 12 weeks, urine protein quantity of 24 hours of experimental
group are decreased, serum protein has increased, and significant difference
(p < 0.05), the control group at 24 weeks after 24 hours urinary protein
quantitative decline, increased serum protein have significant difference
(p < 0.05), there was no significant difference in elf inhibition quantitative
C, cholesterol, serum creatinine in two groups (p > 0.05).
Conclusion: The leflunomide combined hormone has significant curative ef-
fect for treatment of IgAN compared to the use of hormone.Figure 2 P+M staining and immunofluorescence staining of IgA in kidney
tissue of each group of rats.http://dx.doi.org/10.1016/j.hkjn.2015.08.110
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Jia Lining, Fu Rongguo, Gui Baosong, Zhang Xinying, Wang Li, Ma Xiaotao
Department of Nephropathy, The Second Affiliated Hospital of Xi’an
Jiaotong University, Xi’an, China
Objective: To investigate the LPC program (prednisone, leflunomide and
traditional Chinese medicine) in IgA nephropathy rats and its possible
mechanism.
Methods: Forty-two healthy female SD rats were divided into model and
control groups. At the end of 12th week, the rats model of IgA nephrop-
athy had been established successfully, the model rats were dividedrandomly and equally into four groups which contained M group (model
control group), LPC group (prednisone, leflunomide and traditional Chi-
nese medicine group), LP group (prednisone and leflunomide group)
and C group (traditional Chinese medicine group), 24-hour urine protein
were examined every 2 weeks. At the last day of the 18th week, all rats
were sacrificed and their blood taken out to be examined for Scr, Alb by
biochemistry. He, Masson, PAS and P+M staining and immunofluorescence
staining of IgA in kidney tissue of each group rats were used to visualize
pathologic morphology damage. The expression of nephrin and podocin in
kidney tissue was examined by RT-PCR.
Results: At the end of the 12th week, a higher 24-hour proteinuria could be
seen in group M compared with normal group (P < 0.05); IgA complex deposit
were also shown which improves the animal model is successful. Compared
with group M, proteinuria and serum creatinine were decreased, while Alb
was increased in LPC group (P < 0.05). Decreased pathologic damage of
renal tissue also existed in the mesangial region of glomeruli and conspicu-
ous IgA complex deposit were also shown. The expression of nephrin and
podocin mRNA were increased in LPC group (P < 0.05).
Conclusion: The combination of prednisone, leflunomide and traditional
Chinese medicine has better effect in treatment of rats with IgAN than
sole of prednisone and leflunomide or traditional chinese medicine. The
mechanism may be concerned with the reduction of IgA immune complex
deposit, up-regulate the expression of nephrin and podocin in kidney tissue.http://dx.doi.org/10.1016/j.hkjn.2015.08.111
